PolyNovo Ltd. announced the appointment of Mr. Swami Raote as Chief Executive Officer (CEO), effective immediately. Mr. Raote has extensive and deep leadership experience including a 30-year career at Johnson & Johnson where he was a transformation growth leader across FMCG, OTC, pharmaceuticals, and medical devices. Mr. Raote held senior leadership positions at Johnson & Johnson across various geographies of interest to PolyNovo including Indonesia, ASEAN, India, China, South Korea, and the U.S.A. Mr. Raote's most recent role was Worldwide President for J & J's Vision Care, a business with 5,600 employees across 120 countries and 2 manufacturing and research and development sites.

At Vision Care, he accelerated growth in the U.S., China, Japan, and key Western European markets. PolyNovo's Chairman, David Williams thanked Mr. Max Johnston for acting as CEO since November 2021 during which time he realigned focus on key strategic objectives, operational improvements, and company culture. Biography of Swami Raote: During his 30-year tenure with Johnson & Johnson Swami earned a reputation as a trusted transformative growth leader across fast-moving consumer goods, over the counter products, pharmaceuticals, and medical devices.

He has delivered results through globalising innovation, making strategic portfolio choices through acquisitions and divestures, while building aligned inspired teams. He has successfully delivered results, building robust organizations for over 20 years in developed and emerging Asia, with a decade in the U.S. Mr. Raote is currently an Advisor to the Prime Minister of a major Asian country that is building a digital health platform. He also has a number of other advisory roles which will be reviewed to determine their relevance to PolyNovo. Mr. Raote completed a bachelor's degree in Pharmaceutical Sciences and has an MBA from the Indian Institute of Management in Calcutta where he was recently honoured with a Distinguished Alumnus award.

Mr. Raote has completed numerous executive programs at Harvard Business School including Advanced Management, Digital Health, and Preparing for Corporate Boards.